story of the week
Occurrence and Implications of Neratinib-Associated Diarrhea in Patients With HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patterns of Occurrence and Implications of Neratinib-Associated Diarrhea in Patients With HER2-Positive Breast Cancer: Analyses From the Randomized Phase III Extenet Trial
Breast Cancer Res 2019 Feb 27;21(1)32, J Mortimer, J Di Palma, K Schmid, Y Ye, M JahanzebFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.